Conference Day 1, Thursday 13 November 2025 (4pm to 8pm)
Audience: Physicians from Internal Medicine, primary health care, Rhinology, pulmonology and allergists in the private section as well as those from locally, regionally and internationally
Location: Le Royal Meridien, Lusail, Doha, Qatar
Overall Objectives:
- To have an overview of severe asthma management
- To discuss the current state of science in food allergies
- To be aware of the available biologic for severe asthma and CRSwNP
- To have an overview of the use of allergen immunotherapy to treat allergic diseases
Time |
Topic |
Speaker |
3.30pm to 4pm |
Registration |
ALL |
Session 1: Allergen Immunotherapy Moderators: Dr Pascal Demoly (France), Dr Fatima Ashkanani (Qatar)
|
4pm to 4.30pm |
Allergen Immunotherapy from Clinical Trials to Real-Life Studies Objective: To identify the types and indications of AIT |
Prof. Moises Calderon (UK) |
4.30pm to 5pm |
Food Immunotherapy Current Answers and Unresolved Questions Objective: To discuss the indications and limitations of AIT for food allergy |
Dr Davide Caimmi (France) |
5pm to 5.10pm |
Questions and discussion |
|
5.10pm to 5.20pm |
Prayer & Break |
|
Session 2: Biologics in Severe Asthma part 1 Moderators: Dr Loie Goronfolah (KSA), Dr Tayseer Ibrahim (Qatar)
|
5.20pm to 5.50pm |
How to Choose Biological Agents in Severe Asthma Objective: To discuss the factors that help in the selection of biological treatment |
Dr Juan Carlos Cardet (USA) |
5.50pm to 6.20pm |
Remission, Response and Non-response in Asthma Objective: To have an overview of remission in asthma and how to assess the response of severe asthma to treatment |
Dr Hassan Mobayed (Qatar) |
6.20pm to 6.30pm |
Questions and discussion |
|
6.30pm to 6.40pm |
Prayer & Break |
|
Session 3: Biologics in Severe Asthma part 2 Moderators: Dr Mona Al-Ahmad (Kuwait), Dr Rmazy Ali (Qatar)
|
6.40pm to 7.05pm |
What is New in CRSwNP? Objective: To discuss updates in CRSwNP management |
Dr Tayseer Ibrahim (Qatar) |
7.05pm to 7.30pm |
Severe Asthma Diagnosis and Management Update in 2025 Objective: To have an overview of updates in severe asthma diagnosis and management |
Dr Connie Katelaris (Australia) |
7.30pm to 7.55pm |
Real-world Data on Severe Asthma Patients from the International Severe Asthma Registry (ISAR) Objective: To discuss severe asthma patients' data from the ISAR |
Dr. Désirée Larenas-
Linnemann (Mexico) |
7.55pm to 8.10pm |
Questions and discussion |
|
End of Day 1 |